## Clinical Scenario Analysis This patient presents with acute ischemic stroke in the setting of **untreated atrial fibrillation**. The irregular pulse on examination confirms AF. ### Pathophysiology of Cardioembolic Stroke in AF **Key Point:** Atrial fibrillation causes loss of organized atrial contraction, leading to blood stasis particularly in the **left atrial appendage (LAA)**. Stasis promotes thrombus formation. **High-Yield:** The left atrial appendage is the source of thrombi in 90% of cardioembolic strokes due to AF. The LAA has a narrow neck and complex anatomy that traps blood during AF. ### Why LAA Thrombus Forms 1. **Loss of atrial contractility** → blood stasis in LAA 2. **Endothelial injury** from abnormal flow patterns 3. **Hypercoagulability** (AF itself increases thrombotic tendency) 4. **Virchow's triad satisfied:** stasis (primary), endothelial injury (secondary), hypercoagulability (tertiary) ### Comparison of Cardioembolic Sources | Source | Clinical Context | Frequency in AF | |--------|------------------|------------------| | LAA thrombus | AF without anticoagulation | 90% of cardioemboli | | Mural thrombus | Post-MI with akinetic segment | Acute MI phase | | Atherosclerotic plaque | Carotid stenosis >50% | Arterial source, not cardiac | | PFO paradoxical embolism | Venous thromboembolism + PFO | Requires VTE source | **Clinical Pearl:** This patient has no history of recent MI (no mural thrombus), no evidence of carotid disease (no TIA/amaurosis fugax prodrome), and no mention of DVT/PE (no PFO paradoxical route). The **irregular pulse + AF history + no anticoagulation** = LAA thrombus. **Mnemonic:** **CHADS₂** score predicts stroke risk in AF; this patient has C (CHF/LV dysfunction risk), H (Hypertension), A (Age ≥75 or 65–74 with risk factors), D (Diabetes), S (prior Stroke/TIA/thromboembolism). Even one point warrants anticoagulation; this patient should have been on warfarin or DOAC. ### Prevention & Management - **Anticoagulation** (warfarin INR 2–3 or DOAC) reduces stroke risk by ~65% in AF - **LAA closure devices** (Watchman, LAAC) for patients with contraindications to anticoagulation - **Aspirin alone** is insufficient in AF with stroke risk factors 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.